Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3046 Target Snapshot

Sialidase-3 · SINGLE PROTEIN · Homo sapiens

252Compounds
41Assays
2Approved Drugs
291.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9UQ49. Use UniProt Q9UQ49 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9UQ49 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sialidase-3 as ChEMBL target CHEMBL3046, mapped to UniProt Q9UQ49. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sialidase-3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3046
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9UQ49
Sialidase-3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sialidase-3 is the right protein anchor across sources, using UniProt Q9UQ49 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSialidase-3
UniProt AccessionQ9UQ49
Component TypeProtein
Sequence Length428 aa

Sialidase-3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sialidase-3, mapped to UniProt Q9UQ49. Sequence length is 428 aa.

Mapped IDQ9UQ49
Review nameSialidase-3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC50271.0
KI20.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4076203 6.55 Ki 280.0 Preclinical
CHEMBL4099818 6.5 Ki 320.0 Preclinical
CHEMBL4099818 6.24 IC50 580.0 Preclinical
CHEMBL222813 6.21 Ki 620.0 Approved
CHEMBL4064112 6.21 IC50 610.0 Preclinical
CHEMBL4076203 6.16 IC50 700.0 Preclinical
CHEMBL4062382 6.0 IC50 1000.0 Preclinical
CHEMBL4071732 5.96 IC50 1100.0 Preclinical
CHEMBL96712 5.8 Ki 1600.0 Preclinical
CHEMBL96712 5.62 IC50 2400.0 Preclinical
Distribution

pChEMBL Value Distribution

43
5.0
9
5.5
12
6.0
3
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ZANAMIVIR
CHEMBL222813
Approved 1999
Assay Landscape

Assay Landscape

41
Total Assays
99
Tested Compounds
1
Assay Types
Binding — 41 assays, 99 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 22 77 5.1
cell-based format 12 6 4.7
single protein format 7 16 4.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine